Evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis from clinical samples

British Journal of Biomedical Science

Volumn 65, Issue 1, 2008, Pages 7-12

  Barber, Patricia ^a  

^a NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Amplification tests; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BD PROBETEC ET; BIOASSAY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; LABORATORY TEST; LIQUID CULTURE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 41749121709     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2008.11732787     Document Type: Article

References (32)

1. World Health Organization. Global plan to stop TB 2006-2015. Geneva: WHO, 2006 (Document No. WHO/HTM/STB/2006.35).
2. Department of Health. Stopping tuberculosis in England: an action plan from the Chief Medical Officer. London: Department of Health, 2004.
3. Rose AM, Watson JM, Graham C et al. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 2001; 56: 173-9.
4. British Thoracic Society. Control and prevention of tuberculosis in the UK: code of practice 2000. Thorax 2000; 55: 887-901.
5. www.hpa.org.uk/infections/topics_az/tb/menu.htm
6. World Health Organization. Tuberculosis. Information Fact Sheet No. 104. www.who.int/mediacentre/factsheets
7. Golub JE, Bur S, Cronin WA et al. Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis 2006; 10: 24-30.
8. Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ 2006; 332: 1194-7.
9. Watterson SA, Drobniewski FA. Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol 2000; 53: 727-32.
10. Primm TP, Lucer CA, Falkinham III JO. Health impacts of environmental mycobacteria. Clin Microbiol Rev 2004; 17: 98-106.
11. Schluger NW. Changing approaches to the diagnosis of tuberculosis. Am J Respir Crit Care Med 2001; 164: 2020-4.
12. Rüsch-Gerdes S, Richter E. Clinical evaluation of the semiautomated BDProbeTec ET system for the detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. Diagn Microbiol Infect Dis 2004; 48: 265-70.
13. White VL, Moore-Gillon J. Resource implications of patients with multidrug-resistant tuberculosis. Thorax 2000; 55: 962-3.
14. Drobniewski FA, Watterson SA, Wilson SM et al. A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol 2000; 49: 271-8.
15. Doherty TM, Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet 2006; 367: 947-9.
16. Drobniewski FA, Caws M, Gibson A et al. Modern laboratory diagnosis of tuberculosis. Lancet 2003; 3: 141-7.
17. Wright PW, Wallace Jr. RJ, Wright NW et al. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria. J Clin Microbiol 1998; 36: 1046-9.
18. Llorin O, Brink T, Bustos S et al. Evaluation of the BDProbeTec ET system for the direct detection of Mycobacterium tuberculosis complex from smear-negative respiratory samples. American Society for Microbiology. 99th General Meeting, May 1999.
19. Chappell M. Tuberculosis in Northamptonshire - Annual Report 2005. Northampton Primary Care Trust.
20. Cheng VC, Yam WC, Hung IF et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 2004; 57: 281-5.
21. Bland M. An introduction to medical statistics (3rd edn). Oxford: Oxford University Press, 2000: 275-9.
22. Schwarzman K. Latent tuberculosis infection: old problem, new priorities. CMAJ 2002; 166: 759-61.
23. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006; 129: 1653-72.
24. Behr MA, Warren SA, Salamon H et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-9.
25. National Institute for Health and Clinical Excellence. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis and measures for its prevention and control. London: Royal College of Physicians, 2006.
26. Mazurek GH, Cave MD, Eisenach KD et al. Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiological study of tuberculosis. J Clin Microbiol 1991; 29: 2030-3.
27. McHugh TD, Newport LE, Gillespie SH. IS6110 homologs are present in multiple copies in mycobacteria other than tuberculosis-causing mycobacteria. J Clin Microbiol 1997; 35: 1769-71.
28. Johansen LS, Thomsen VØ, Johansen A et al. Evaluation of a new commercial assay for diagnosis of pulmonary and nonpulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 2002; 21: 455-60.
29. Lok KH, Benjamin WH Jr, Kimerling ME et al. Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions. Emerg Infect Dis 2002; 8: 1310-3.
30. Hellyer TJ, Fletcher TW, Bates JH et al. Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. J Infect Dis 1996; 173: 934-41.
31. Bergmann JS, Keating WE, Woods GL. Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 863-5.
32. Barrett A, Magee JG, Freeman R. An evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis in respiratory samples. J Med Microbiol 2002; 51: 895-8.